Cooper Companies

The Cooper Cos, Inc. operates as a medical device company. It operates through the Cooper Vision and Cooper Surgical segments. The Cooper Vision segment develops, manufactures, and markets products for contact lens wearers, which solves vision challenges such as astigmatism, presbyopia, myopia, ocular dryness, and eye fatigues. The Cooper Surgical segment focuses on the provision of advancement for the health of women, babies, and families through women's health and fertility products and services. The company was founded in 1958 and is headquartered in San Ramon, CA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Cooper Companies excels in Q1, eyes growth through strategic initiatives

Cooper Companies delivered exceptional Q1 results, surpassing revenue and earnings expectations. With a focus on innovation, operational efficiency, and strategic acquisitions, the company is well-positioned for continued growth despite economic uncertainties and supply chain challenges.

Cooper Companies reports record Q2 revenues amidst industry challenges

Cooper Companies delivered a strong Q2 performance with record revenues and solid earnings per share, driven by CooperVision and CooperSurgical.
While facing industry-wide supply chain challenges, Cooper's strategic strengths in product portfolios and geographic diversification position it well for future growth.
Opportunities lie in leveraging successful product lines, addressing operational challenges, and expanding into international markets for sustained growth.
Overall, Cooper remains optimistic about its future growth prospects in the contact lens and fertility markets, despite facing some challenges.

Cooper Companies reports record revenues and optimistic outlook for growth

Cooper Companies delivered strong financial performance, exceeding revenue expectations and showcasing growth in key segments. The company is strategically positioned for sustained growth, with a focus on leveraging market opportunities and optimizing infrastructure investments. Challenges in managing growth and SKU ranges are being addressed to drive future profitability.

Cooper Companies reports record revenues and projects strong growth ahead

Cooper Companies had a stellar year, marked by record revenues and robust growth in key segments. Despite challenges in capacity and cash flow, the company is poised for continued success with confidence in overcoming obstacles. Opportunities in Myopia management, price trends, and share gains position Cooper Companies for a promising future.

Cooper Companies reports record Q1 revenues, eyes global growth opportunities

Cooper Companies delivered a strong Q1 performance with record revenues and raised full-year guidance. The company's focus on key growth areas like myopia management and daily contact lenses bodes well for future success. Addressing challenges in capacity constraints and market fluctuations will be crucial for sustained growth.

Cooper Companies (COO) reports record revenues and growth opportunities

Cooper Companies (COO) reports strong Q2 earnings with record revenues and increased guidance for fiscal 2024. Challenges include system upgrade impact and competitive uncertainties, but opportunities lie in market growth and strategic investments for future growth.

Cooper Companies (COO) excels in Q3 with record revenues and growth

Cooper Companies (COO) showcased robust financial performance in Q3 2024, driven by record revenues and earnings growth across its key segments.
While facing challenges in certain product lines, strategic investments and market-leading positions position the company well for future growth and profitability.
With a focus on innovation and operational excellence, Cooper Companies is poised to capitalize on opportunities for sustained success and market expansion.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

The Cooper Companies (COO) delivered earnings and revenue surprises of 3.33% and 5.36%, respectively, for the quarter ended July 2021. Do the numbers hold clues to what lies ahead for the stock?

The Cooper Companies (COO) Q3 Earnings and Revenues Top Estimates

SAN RAMON, Calif., Sept. 02, 2021 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) today announced financial results for its fiscal third quarter ended July 31, 2021.

CooperCompanies Announces Third Quarter 2021 Results

MONTRÉAL--(BUSINESS WIRE)--CooperVision Canada, a global leader in myopia management, today announced that popular Québec pop singer, entrepreneur, actress, television and radio host Mitsou Gélinas has become their new spokesperson for a campaign to raise awareness about myopia in children. This new campaign featuring Mitsou will focus on the causes, tips for prevention and options for treatment of myopia in children. Spanning several weeks, the campaign will consist of advertising buys and int

CooperVision Proudly Names Mitsou as Québec Spokesperson to Raise Awareness Around Myopia in Children

CooperVision, a unit of Cooper Companies (COO), receives approval for MiSight 1 day contact lenses from China's National Medical Products Administration for use in China.

Cooper Companies (COO) Unit's MiSight Gets Approval in China

The Cooper Companies (COO) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Strength Seen in The Cooper Companies (COO): Can Its 7.8% Jump Turn into More Strength?

SAN RAMON, Calif., Aug. 12, 2021 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), will participate in the Virtual Wells Fargo Healthcare Conference on Friday, September 10, 2021. Al White, President and CEO, will represent the Company in a virtual session scheduled to begin at 1:20PM ET.

CooperCompanies to Participate in the Virtual Wells Fargo Healthcare Conference

SAN RAMON, Calif., Aug. 12, 2021 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), today announced that the Chinese National Medical Products Administration (NMPA), which regulates medical devices and pharmaceuticals in China, has approved CooperVision MiSight® 1 day contact lenses for use within the country following a priority review.

CooperCompanies Announces MiSight® Approval in China

CONSOL Energy

Lennar

Morgan Stanley

Invesco S&P SmallCap 600 Pure Value ETF

Domtar

Veritiv

These cheap value stocks are strong and competitive companies traded at discounted price levels -- and they could mean solid returns. The post 7 Cheap Value Stocks To Buy For August 2021 appeared first on InvestorPlace.

7 Cheap Value Stocks To Buy For August 2021

SAN RAMON, Calif., July 29, 2021 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), today announced it will release third quarter 2021 financial results on Thursday, September 2, 2021, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments.

CooperCompanies Announces Release Date for Third Quarter 2021

D.R. Horton

Fox Corporation Class A

Progressive

Clients and prospects often say to me, “With the market at all-time highs, isn't this a bad time to invest?”

The Market's Expensive, but Some Stocks Aren't

Henry Schein

HSIC vs. COO: Which Stock Is the Better Value Option?

The Cooper Companies continues to present a compelling investment case. This case is backed by robust end markets in myopia in which the company holds key expertise.

The Cooper Companies: Growth In End Markets Likely

TORONTO--(BUSINESS WIRE)--While the horizon of a return to normal seems less distant, a new survey by CooperVision Canada and Maru/Blue1 suggests that the pandemic may have generated near-vision habits, which according to experts could have an impact on the eye health of Canadian children, including myopia2. More commonly called nearsightedness, myopia is the inability to see objects clearly at a distance and can be worsened by the overuse of near vision3 and the lack of natural light4. There a

No Rest for the Weary Eyes: A Pandemic of Increased Near-Vision Use for Canadian Children(1) – CooperVision Survey

Helen of Troy

Intel

Skyworks Solutions

Tyson Foods

According to the GuruFocus All-in-One Screener, a Premium feature, as of June 22, the following guru-held companies have positive future earnings estimates from Morningstar analysts.

5 Guru Stocks Expected to Boost Earnings

SAN RAMON, Calif., June 15, 2021 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) announced today the publication of its first Environmental, Social, and Governance (ESG) Report, highlighting the Company's progress on ESG items most important to its businesses and stakeholders, including employees, shareholders, customers, and global communities.

CooperCompanies Releases 2020 Environmental, Social, and Governance Report

Anthem

Emergent BioSolutions

Humana

Jazz Pharmaceuticals

According to the GuruFocus All-in-One Screener, a Premium feature, the following guru-owned defensive companies have grown their book value per share over the past decade through June 14.

5 Defensive Stocks Trading With Low Book Value

Cooper Companies' (COO) fiscal second-quarter 2021 earnings reflect solid segmental performance.

Cooper Companies (COO) Q2 Earnings Top Estimates, '21 View Up

The Cooper Companies, Inc. (COO) CEO Al White on Q2 2021 Results - Earnings Call Transcript

Shares of Cooper Companies (NYSE:COO) increased in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share increased 123.84% over the past year to $3.38, which beat the estimate of $3.09.

Recap: Cooper Companies Q2 Earnings

SAN RAMON, Calif., June 03, 2021 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) today announced financial results for its fiscal second quarter ended April 30, 2021.

CooperCompanies Announces Second Quarter 2021 Results

The Cooper Companies, Inc. (NYSE:COO) is a global medical device company that operates through two business units, CooperVision and CooperSurgical.

Here's Why Cooper Companies Stock Valuation May Be Deceiving

Cooper Companies' (COO) unit CooperVision's latest orthokeratology contact lens becomes the latest myopia control product to gain European approval.

Cooper Companies (COO) Unit's Ortho-K Lens Receives CE Mark

The Cooper Companies (COO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

The Cooper Companies (COO) Reports Next Week: Wall Street Expects Earnings Growth

SAN RAMON, Calif., May 25, 2021 /PRNewswire/ -- CooperVision Specialty EyeCare's Procornea DreamLite ® night lenses have received European approval for slowing the progression of myopia in children and young adults.

CooperVision DreamLite® Ortho-K Lenses Gain European Approval for Slowing Progression of Myopia

SAN RAMON, Calif., May 12, 2021 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) announced today that its Board of Directors has elected Dr. Maria Rivas as an independent director, effective July 1, 2021.

News for Cooper Companies Stock (COO)